MedPath

Comparative clinical study of godanti-gairika vati and godanti-kasisa vati in pandu ( iron deficiency anaemia) and pharmaceutico-analytical study of these two vati.

Phase 3
Conditions
Health Condition 1: D509- Iron deficiency anemia, unspecified
Registration Number
CTRI/2022/11/047470
Lead Sponsor
Principal, R.G.G.P.G. Ayurvedic College and Hospital Paprola, Distt. Kangra, H.P.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients willing for clinical trial and ready to give written consent.

2.Patients having Hb more than 8gm% but less than 10gm%.

3.Patients possessing sign and symptoms of Pandu roga on the basis of diagnostic criteria.

4.Patients not having any associated chronic ailment.

Exclusion Criteria

1.Patients having Hb less than 8gm% or more than 10 gm %.

2.Patients with further complications of Pandu roga such as hridroga, shotha etc.

3.Congenital anaemia like sideroblastic anaemia, congenital dyserythropoetic anaemia, thalessemia, sickle cell anaemia, aplastic anaemia etc.

4.Patients having blood loss due to haemorrhoids, ulcers and epistaxis.

5.Patients suffering from AIDS, Cancer, TB, Diabetes mellitus or any other severe systemic dissorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relieve in symptoms like palpitations, dryness, lack of sweating and fatigue, tinnitus, pallor, generalised weakness, vertigo, excessive sleep, pain in the calf muscle, swelling around the eye, anorexia.Timepoint: 45 days trial period
Secondary Outcome Measures
NameTimeMethod
Complete remission of sign and symptoms. <br/ ><br>Improved haemoglobin levels of patients.Timepoint: Follow up 1 month after completion of trial
© Copyright 2025. All Rights Reserved by MedPath